M3 Global Research is part of M3 Inc. Founded in 2000, M3 is listed on the Tokyo Stock Exchange (joining the NIKKEI 225 in 2019), and is ranked in Forbes’ 2020 Global 2000 list, and Fortune's 2020 Future 50 index. M3’s legacy lies in the power of trusted physician platforms. Around the world, M3 organisations leverage these highly engaged digital communities to deliver medical education, job placement, and market research, to improve global patient outcomes. Beyond market research, we offer additional opportunities for engagement including physician recruitment and medical education, strengthening the responsiveness of our panel members.